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        Langerhans cells (LCs) constitute a subset of DCs. 
In their immature state, they reside in the stratifi  ed 
squamous epidermal layer of the skin and in the 
mucosal epithelia lining the ocular, oral, and 
vaginal surfaces. LCs are thought to detect patho-
gens that penetrate epithelial barriers and, 
after undergoing a phase of maturation, con-
vey this information via lymphatic vessels to T 
cells present in LNs (  1  –  3  ). Recent data suggest 
that migratory LCs play an indirect role in T cell 
priming, possibly in carrying over antigens to 
those DCs that reside throughout their life cycle 
in LNs (  4  ). These last DCs are denoted as lym-
phoid tissue  –  resident DCs to distinguish them 
from tissue-derived (migratory) DCs (  5, 6  ). 
Lymphoid tissue  –  resident DCs are categorized 
into CD8      +   and CD8            subsets and have an 
  “  immature  ”   phenotype, which is characterized 
by low levels of MHC class II (MHCII) and co-
stimulatory molecules. They collect and present 
antigens in the lymphoid organ itself, and they 
can respond to activatory signals and mature in 
situ. In addition to LCs, the skin contains a 
second type of DC, the dermal DC (DDC). 
Epidermal LCs and DDCs can migrate to cuta-
neous-draining LNs (CLNs) under both steady-
state and infl  ammatory conditions, and they 
constitute the direct precursors of the epidermal 
LC- and DDC-derived DCs found in CLNs, 
respectively. These two types of skin-derived 
DCs express a   “  mature  ”   phenotype, which is 
characterized by a CD11c  inter to high  , MHCII  high   
phenotype and high levels of costimulatory mol-
ecules. Tissue-derived DCs are also found in 
LNs that do not drain skin territories, such as 
mesenteric LNs (MLNs), and likely represent 
the progeny of interstitial DCs found in the pa-
renchyma of nonlymphoid tissues. 
  Langerin (CD207) is a C-type lectin that is 
expressed in LCs (  7, 8  ). To track LCs in vivo 
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  Langerhans cells (LCs) constitute a subset of dendritic cells (DCs) that express the lectin 
langerin and that reside in their immature state in epidermis. Paradoxically, in mice 
permitting diphtheria toxin (DT)  –  mediated ablation of LCs, epidermal LCs reappeared with 
kinetics that lagged behind that of their putative progeny found in lymph nodes (LNs). 
Using bone marrow (BM) chimeras, we showed that a major fraction of the langerin  +  , 
skin-derived DCs found in LNs originates from a developmental pathway that is indepen-
dent from that of epidermal LCs. This pathway, the existence of which was unexpected, 
originates in the dermis and gives rise to langerin  +   dermal DCs (DDCs) that should not be 
confused with epidermal LCs en route to LNs. It explains that after DT treatment, some 
langerin  +  , skin-derived DCs reappear in LNs long before LC-derived DCs. Using CD45 expression 
and BrdU-labeling kinetics, both LCs and langerin  +   DDCs were found to coexist in wild-type 
mice. Moreover, DT-mediated ablation of epidermal LCs opened otherwise fi  lled niches 
and permitted repopulation of adult noninfl  ammatory epidermis with BM-derived LCs. 
Our results stress that the langerin  +   DC network is more complex than originally thought 
and have implications for the development of transcutaneous vaccines and the improve-
ment of humanized mouse models. 3120 DUAL ORIGIN OF LANGERIN  +   SKIN-DERIVED DCS | Poulin et al.
tissue  –  resident, langerin  low   CD8      +   DCs that are found in 
CLNs and are continuously renewed from blood-precursors. 
There is currently no explanation for this unanticipated ob-
servation. In this study, we demonstrate that a major fraction 
of the langerin  +  , skin-derived DCs found in steady-state CLNs 
follows a developmental pathway that is both independent 
from and proceeds at a faster pace than that of epidermal LCs 
and their derivatives. 
    RESULTS   
  Dual origin of the langerin  +   DCs found in CLNs 
  Considering that the expression of the  Lang-DTR-EGFP   allele 
results in dimmer EGFP fl  uorescence than that of the   Lang-
EGFP   allele, and that a single copy of the   Lang-DTR-EGFP   
allele renders langerin  +   DCs sensitive to DT (  9  ), we systemat-
ically used mice with a   Lang-EGFP/Lang-DTR-EGFP   geno-
type to track LCs in vivo and facilitate depletion monitoring. 
For the sake of brevity,   Lang-EGFP/Lang-DTR-EGFP   mice 
are subsequently denoted as   Lang-DTR-EGFP   mice. To re-
visit the origin of the langerin  +  , CD11c  inter to high  , MHCII  high   
DCs found in steady-state CLNs, C57BL/6 mice expressing 
the CD45.1 allele (B6 [CD45.1]) were lethally irradiated and 
reconstituted with BM cells isolated from   Lang-DTR-EGFP   
mice expressing the CD45.2 allele. These chimeras, called 
  Lang-DTR-EGFP     →   B6 (CD45.1) chimeras, were analyzed 
8 wk after transplantation. At that time,   >  99% of blood B cells 
were of donor origin (Fig. S1, available at http://www.jem
.org/cgi/content/full/jem.20071724/DC1), and the radio-
sensitive DC subsets were made of BM-derived DCs only 
(Fig. S2 and Fig. S3). Owing to their radioresistance (  12  ), all 
the epidermal LCs found in   Lang-DTR-EGFP     →   B6 (CD45.1) 
chimera 8 wk after BM transplantation were of host (CD45.1  +  ) 
origin and expressed langerin, but no EGFP ( Fig. 1 A ), con-
fi  rming that in the absence of major skin injury there is no 
input of donor-derived cells to the pool of epidermal LCs.   
In contrast, LCs from epidermal sheets of   Lang-DTR-EGFP   
control mice expressed both langerin and EGFP (  Fig. 1 A  ). The 
tissue-derived (CD11c  inter to high  , MHCII  high  ) DCs found in 
CLNs of   Lang-DTR-EGFP     →   B6 (CD45.1) chimera segregated 
into a langerin        and langerin  +   fraction and, consistent with 
a recent study (  13  ),   >  90% of the DDC-derived DCs were 
of donor origin (  Fig. 1 B  ). Provided LCs constitute the only 
reservoir of the langerin  +  , CD11c  inter to high  , MHCII  high   DCs 
found in the CLNs of   Lang-DTR-EGFP     →   B6 (CD45.1) 
chimeras, these last cells should constitute a homogeneous 
CD45.1  +  , EGFP        population. However, they segregated into 
a CD45.1  +  , EGFP        subset, which likely derives from the 
migration of radioresistant, B6 (CD45.1)-derived LCs (  Fig. 
1 A  ), and into a donor-derived (CD45.2  +  , EGFP  +  ) subset, 
the existence of which was unexpected and the immediate 
precursors of which do not reside in the epidermis. Therefore, 
the langerin  +  , CD11c  inter to high  , MHCII  high   DCs found in CLNs 
do not derive exclusively from migratory epidermal LCs. 
  The unexpected subset of donor-derived, langerin  +   DCs 
found in steady-state CLNs of   Lang-DTR-EGFP     →   B6 
(CD45.1) chimeras does not constitute a minor component 
and distinguish them from DDCs,   Lang-EGFP   mice that 
express an enhanced GFP (EGFP) under the control of the 
  langerin   gene were engineered (  9  ). Although langerin expres-
sion is down-regulated upon LC maturation, LCs still retain de-
tectable levels of langerin once they reach CLNs (  10  ), and 
langerin  +   DCs could be readily identifi  ed in the T cell zone 
of steady-state CLNs (  9  ). However, langerin alone is not a 
reliable marker to identify LC-derived DCs outside the skin 
because most CD8      +   DCs present in CLNs, MLNs, and the 
spleen express langerin, albeit at lower levels than LCs (  9  ). 
Therefore, lymphoid tissue  –  resident DCs diff  erentiating from 
blood precursors can express langerin without having to re-
side fi  rst within epithelia. Because they do not drain skin 
territories, the spleen and MLNs contain only langerin  low   
CD8      +   DCs, whereas CLNs contain both lymphoid tissue  –
  resident, langerin  low  , CD8      +   DCs and skin-derived, langerin  +  , 
CD8           to low   DCs. 
  Epidermal LCs renew throughout life from local cells that 
seed the skin around birth (  11, 12  ). Importantly, the cells en-
suring epidermal LC renewal are radiation resistant, and after 
lethal irradiation and BM transplantation, epidermal LCs and 
their derivatives found in CLNs remain of host origin 
throughout life (  12  ). In contrast, all other DC subtypes, in-
cluding most DDCs, are radiosensitive and replaced by do-
nor-derived cells (  13  ). Experiments based on parabiotic mice 
have suggested that, akin to epidermal LCs, some lymphoid 
tissue  –  resident DCs are replaced by locally derived, long-
lived precursors, and thus do not depend on the continuous 
extravasation and diff  erentiation of blood precursors (  14  –  16  ). 
However, this view has been recently challenged (  17  ), and in 
steady-state conditions, lymphoid tissue –  resident DC homeo-
stasis likely results from three processes that consist of constant 
replenishment by DC precursors from blood, limited in situ 
divisions, and cell death. 
  Knock-in mice expressing a diphtheria toxin (DT) recep-
tor (DTR) cDNA under the control of the   langerin   gene 
(  Lang-DTR-EGFP   mice) were used to study the dynamics of 
LCs in vivo (  9, 18  ). Expression of the DTR-EGFP fusion 
protein conferred DT sensitivity to langerin  +   DCs, whereas 
other DC subsets remained resistant to DT treatment. DT 
treatment resulted in no sign of skin infl  ammation, and 24 h 
after a single injection of DT the whole population of epider-
mal LCs was eliminated (  9, 18  ). 2 wk after DT treatment, 
sparse patches of LCs were observed in the epidermis, and it 
is only 8 wk after DT treatment that epidermal LC reconsti-
tution was close to completion. According to currently ac-
cepted views, langerin  +  , CD11c  inter to high  , MHCII  high   DCs 
present in steady-state CLNs constitute terminally diff  erenti-
ated cells that are endowed with a short half-life and that are 
continuously replaced by migratory LCs. After DT treatment, 
the kinetics of reappearance of the langerin  +  , CD11c  inter to high  , 
MHCII  high   DCs found in CLNs was thus expected to lag 
behind that of epidermal LCs. Unexpectedly, the langerin  +  , 
CD11c  inter to high  , MHCII  high   DC cells found in CLNs were 
reconstituted over 7 d (  9  ), a kinetics much faster than that of 
epidermal LCs and similar to that of the DT-sensitive, lymphoid JEM VOL. 204, December 24, 2007 
ARTICLE
3121
CLNs represented 69.4   ±   12.5% and 23.6   ±   8.4% of the 
langerin  +  , CD11c  inter to high  , MHCII  high   DCs, respectively 
(  n   = 4). Therefore, the donor-derived langerin  +   DCs found 
in steady-state CLNs of both type of chimeras are two- to 
three-times more abundant than LC-derived DCs. It should 
be stressed that such substantial numbers of donor-derived 
langerin  +   DCs arise in the presence of an epidermis that is 
entirely fi  lled with host-derived LCs. This fi  nding suggests 
that two parallel developmental pathways generate the lan-
gerin  +  , CD11c  inter to high  , MHCII  high   DCs found in steady-
state CLNs. 
of the langerin  +  , CD11c  inter to high  , MHCII  high   DCs. For in-
stance, the donor- and host-derived langerin  +   DCs found in 
the CLNs of   Lang-DTR-EGFP     →   B6 (CD45.1) chimeras 
(  n   = 13) represented 59.7   ±   11.0% and 36.3   ±   9.9% of the 
langerin  +  , CD11c  inter to high  , MHCII  high   DCs, respectively. 
As shown in   Fig. 3 B  , donor- and host-derived langerin  +   DCs 
were also observed in the CLNs of chimeras resulting from 
transfer of B6 (CD45.1) BM cells into lethally irradiated 
  Lang-DTR-EGFP   recipient mice. In this reverse combina-
tion, denoted as B6 (CD45.1)   →     Lang-DTR-EGFP   chi-
meras, the donor- and host-derived langerin  +   DCs found in 
    Figure 1.         Two developmental pathways give rise to langerin  +   skin-derived DCs found in CLNs.   (A) Staining of epidermal sheets from   Lang-
DTR-EGFP    →   B6 (CD45.1) chimeras, wild-type (WT), and   Lang-DTR-EGFP   mice with an anti-langerin antibody (red). As expected, the langerin  +   cells 
found in the epidermis of   Lang-DTR-EGFP   mice differ from those of WT mice and of   Lang-DTR-EGFP    →   B6 (CD45.1) chimeras in that they express 
EGFP. Genotypes are indicated for each column and markers on the left. Results are representative of at least 10 mice of each genotype. (B) Tissue-
derived DCs found in CLNs were defi  ned on the basis of their CD11c  inter to high   MHCII high   phenotype (Fig. S2), and analyzed for the expression of langerin 
versus CD45.2, langerin versus EGFP, and EGFP versus CD45.2. Contour plots from   Lang-DTR-EGFP   CLNs are also included for comparison. The percent-
ages indicated for each window correspond to the percentage of cells among CD11c  inter to high ,  MHCII high   DCs. Results are representative of at least fi  ve 
experiments. (C) Staining of a CLN section from a   Lang-DTR-EGFP    →   B6 (CD45.1) chimera with an anti-langerin antibody (red) shows that host-derived 
(EGFP        langerin +  ) LCs colocalize with donor-derived (EGFP  +   langerin +  ) LCs. A stained section from   Lang-DTR-EGFP   mice is shown for comparison. 
Bars: (A) 50     m; (C) 200    m.   3122 DUAL ORIGIN OF LANGERIN  +   SKIN-DERIVED DCS | Poulin et al.
DTR-EGFP   mice did not result in any deleterious eff  ect (  9  ). 
Therefore, B6 (CD45.1)   →     Lang-DTR-EGFP   chimeras were 
treated with 3 injections of DT 1 wk apart and analyzed at 
various time points after the third injection. 1 d after the last 
DT injection, epidermal sheets of B6 (CD45.1)   →     Lang-
DTR-EGFP   chimeras did not contain any LCs, as detected 
using EGFP expression and antibodies directed against lan-
gerin (  Fig. 2 A  ).   Ear explants from B6 (CD45.1)   →     Lang-
DTR-EGFP   chimeras that had received 3 injections of DT 
were prepared 1 day after the last injection and cultured in 
medium containing the CCL21 chemokine (  20  ). CD11c  +  , 
MHCII  +   DCs migrating out of the ear explants were ana-
lyzed using langerin versus CD45.2 dot plots and epidermal 
  Developmental independence of the two langerin  +   
DC subsets 
  To support the developmental independence of the two 
langerin  +  , CD11c  inter to high  , MHCII  high   DC subsets identifi  ed 
in steady-state CLNs of BM chimeras, B6 (CD45.1)   →     Lang-
DTR-EGFP   chimeras were used to specifi  cally ablate the 
host-derived, DT-sensitive, epidermal LCs and their progeny 
found in CLNs. Provided that donor-derived langerin  +   DCs 
develop independently of host-derived LCs, DT treatment of 
B6 (CD45.1)   →     Lang-DTR-EGFP   chimeras should have no 
eff  ect on them and allow the analysis of this novel subset in 
isolation. In contrast to the situation observed in   CD11c-
DTR-EGFP   mice (  19  ), repeated injections of DT into   Lang-
    Figure 2.         Donor-derived langerin  +   DCs are found in skin explants.   (A) Confocal microscopic analysis of epidermal sheets from B6 (CD45.1)   →    Lang-
DTR-EGFP   chimera that were left untreated (untreated) or had received 3 injections of DT (DT 3 X) a week apart were analyzed 1 d after the last DT 
injection. Staining with anti-langerin antibody (red) revealed the presence of langerin  +   EGFP +   LCs in untreated sheets and their complete absence 1 d 
after the last DT injection. Bars: (untreated panel) 50     m; (DT-treated panel) 300     m. Results are representative of at least two experiments. (B) Ear ex-
plants from B6 (CD45.1)   →    Lang-DTR-EGFP   chimera that had received 3 injections of DT (DT 3 X) were prepared 1 d after the last injection and cultured 
in the presence of CCL21. CD11c  +   MHCII +   cells migrating out of the ear explants were analyzed by using langerin-CD45.2, langerin-EGFP, and EGFP-
CD45.2 plots. Ear explants from untreated B6 (CD45.1)   →    Lang-DTR-EGFP   chimera and   Lang-DTR-EGFP   mice were also included for comparison. 
The percentages indicated for each window corresponds to the percentage of cells among CD11c  + ,  MHCII +   cells. Results are representative of at least 
two experiments.     JEM VOL. 204, December 24, 2007 
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section of ear from DT-treated B6 (CD45.1)   →     Lang-DTR-
EGFP   chimeras 1 day after the last DT injection, confi  rmed 
that langerin  +   EGFP        cells with DC morphology can be read-
ily identifi  ed in the dermis (  Fig. 3 A   and not depicted).    
Therefore, the lack of host-derived, epidermal LCs in DT-
treated B6 (CD45.1)   →     Lang-DTR-EGFP   chimeras 1 day 
after the last DT injection allowed the unambiguous identifi  -
cation of a population of donor-derived, langerin  +   DCs that 
reside in the dermis. Importantly, this experimental model 
prevents these unexpected langerin  +   DCs to be mistakenly 
confounded with epidermal LCs in transit to CLNs. For 
the sake of brevity, the novel population of radiosensitive 
langerin  +   DCs that reside in the dermis will be denoted as 
langerin  +   DDCs. This subset represents approximately a third 
of the langerin  +   DCs capable of being mobilized from ear 
LC-derived DCs were found to be absent (  Fig. 2 B  ). There-
fore, congruent with histological analysis (  Fig. 2 A  ), and with 
previous data (  9, 18  ), DT treatment completely eliminated 
the pool of host-derived, epidermal LCs (CD45.2  +  , EGFP  +  ). 
Langerin  +   DCs with a donor-derived (CD45.2       , EGFP       ) 
phenotype were still found among the cells that migrated out 
of the ear of DT-treated B6 (CD45.1)   →     Lang-DTR-EGFP   
chimeras (  Fig. 2 B  ). In contrast, both donor- and host-de-
rived langerin  +   DCs migrated out from the ear of untreated 
B6 (CD45.1)   →     Lang-DTR-EGFP   chimeras (  Fig. 2 B  ). Con-
sidering that the epidermis of DT-treated B6 (CD45.1)   →   
  Lang-DTR-EGFP   chimeras contains no detectable langerin  +   
cells (  Fig. 2 A  ), it is likely that the population of langerin  +  , 
donor-derived DCs that migrated out of the ear explants 
originated from the dermis. Microscopic examination of 
    Figure 3.     Donor-derived langerin  +   DCs are located in the skin dermis.   (A) Staining of sections of ear from B6 (CD45.1)   →    Lang-DTR-EGFP   chimera 
that had received 3 injections of DT and were prepared 1 d after the last injection were stained with anti-langerin (red) and anti  –  keratin 5 (blue) anti-
bodies. Staining with the anti  –  keratin 5 antibody allowed visualization of the epidermis. Donor-derived, langerin  +   DCs  (EGFP     ,  langerin +  ) are exclusively 
found in the dermis. Bar, 30     m. Ep, epidermis; D, dermis. Results are representative of at least two experiments. (B) CLNs of DT-treated B6 (CD45.1)   →  
  Lang-DTR-EGFP   chimera were collected 1 d after the last DT injection. Tissue-derived (CD11c  inter to high ,  MHCII high  ) DCs were analyzed as described in the 
legend of   Fig. 1   for the expression of langerin-CD45.2, langerin-EGFP, and EGFP-CD45.2. The percentage indicated for each window corresponds to the 
percentage of cells among CD11c  inter to high ,  MHCII high   DCs. Results are representative of at least 4 experiments.     3124 DUAL ORIGIN OF LANGERIN  +   SKIN-DERIVED DCS | Poulin et al.
DT injection and cultured in the presence of CCL21 (  Fig. 4  ).   
CD11c  +  , MHCII  +   cells migrating out of the ear explants were 
analyzed using langerin-EGFP dot plots and the percentage of 
langerin  +   DDCs (langerin  +  , EGFP  +  ) determined (  Fig. 4  ). The 
use of   Lang-DTR-EGFP     →   B6 (CD45.1) chimeras instead 
of   Lang-DTR-EGFP   mice allows us to readily distinguish 
langerin  +   DDCs from LCs. 24 h after the last DT injection, no 
langerin  +   DDCs can be observed among the CD11c  +  , MHCII  +   
cells that migrated out of the ear (  Fig. 4  ). Langerin  +   DDCs re-
appeared around day 4 and their pool was gradually restored 
over the next 14 d (  Fig. 4  ). Confocal microscopic analysis of a 
section of ear from   Lang-DTR-EGFP     →   B6 (CD45.1) chimeras 
14 d after the last DT injection confi  rmed langerin  +   DDC restora-
tion (  Fig. 4  ). Parallel analysis of the langerin  +   DDC-derived DCs 
present in the CLNs of DT-treated   Lang-DTR-EGFP     →   B6 
chimeras showed that they reappeared with kinetics that are 
slightly protracted relative to those of the langerin  +   DDCs 
(  Fig. 4  ), an observation consistent with their postulated pre-
cursor  –  product relationship. 
  The aforementioned data suggest that langerin  +   DDCs 
constitute the reservoir of the langerin  +  , CD11c  inter to high  , 
MHCII  high   DCs that rapidly reappeared in CLNs of   Lang-
DTR-EGFP     →   B6 (CD45.1) chimeras after interruption of 
DT treatment. To support this putative precursor  –  product 
relationship, small pieces of spleen, CLNs, or MLNs from 
B6 (CD45.1) mice were transplanted under the renal capsule 
of B6 (CD45.2) mice. This approach has recently been used 
to show that DC subsets present in the spleen are replen-
ished over a 10  –  14-d period (  17  ). Consistent with that last 
fi  nding, 3 wk after transplantation, most of the DCs found 
in the grafts were of B6 (CD45.2) origin (Fig. S5). Analysis of 
explants upon CCL21 treatment (  Fig. 2 B  ). Therefore, based 
on langerin expression, DDCs can be subdivided into a lan-
gerin  +   and a langerin        subset. 
  Consistent with the lack of LCs in the skin epidermis of 
DT-treated B6 (CD45.1)   →     Lang-DTR-EGFP   chimeras, the 
corresponding CLNs contained no LC-derived (CD45.2  +  , 
EGFP  +  ) DCs (  Fig. 3 B   and not depicted). In contrast, the 
same CLNs contained langerin  +   DCs that showed a tissue-
derived phenotype (CD11c  inter to high  , MHCII  high  ) and origi-
nated from the transplanted BM cells (CD45.2       , EGFP       , 
  Fig. 3 B  ). Altogether, the data obtained using both types of BM 
chimeras support the view that the langerin  +  , CD11c  inter to high  , 
MHCII  high   DCs found in steady-state CLNs have a dual origin. 
The coincidence that exists in DT-treated B6 (CD45.1)   →     Lang-
DTR-EGFP   chimeras between the presence of donor-derived, 
langerin  +   DDCs in the dermis and of donor-derived, langerin  +  , 
CD11c  inter to high  , MHCII  high   DCs in the CLNs sug  gests that a 
precursor-product relationship links them. Con  sistent with that 
view, donor-derived, langerin  +  , CD11c  inter to high  , MHCII  high   
DCs were absent from secondary lymphoid organs (MLNs and 
spleen) that do not drain cutaneous territories (Fig. S2). 
  Kinetics of replacement of langerin  +   DCs after DT ablation 
  If the langerin  +   DDCs identifi  ed in the two types of BM chi-
meras constitute the main reservoir of the langerin  +  , CD-
11c  inter to high  , MHCII  high   DCs found in CLNs, their kinetics of 
restoration after DT treatment should be faster than for their 
putative progeny found in CLNs. To assess the kinetics of re-
appearance of langerin  +   DDCs after DT treatment, ear ex-
plants from DT-treated   Lang-DTR-EGFP     →   B6 (CD45.1) 
chimeras were prepared at various time points after the last 
    Figure 4.         Kinetics of reappearance of donor-derived langerin  +   DCs after DT ablation.   Ear explants and CLNs from   Lang-DTR-EGFP    →   B6  (CD45.1) 
chimeras that had received 3 injections of DT 1 wk apart were prepared at the specifi  ed time points after the last DT treatment. For ears, analysis was 
performed on cells migrating out of CCL21-treated ear explants. Gated DCs (ears, CD11c  +   MHCII +  ; CLNs, CD11c  inter to high   MHCII high  ) were analyzed using 
langerin-EGFP plots. A window corresponding to the langerin  +   EGFP +   subset is shown. The percentage indicated for this window corresponds to the per-
centage of donor-derived, langerin  + ,  EGFP +   cells within the DC gates specifi  ed above. Also shown is a confocal microscopic analysis of a section of ear 
from a DT-treated   Lang-DTR-EGFP    →   B6 (CD45.1) chimera 14 d after the last DT treatment. Staining with anti-langerin (red) and anti-keratin 5 (blue), 
revealed that donor-derived (EGFP  + ),  langerin +   DCs are located exclusively in the dermis, whereas host-derived (EGFP      ),  langerin +   DCs are found in the 
epidermis. Some donor-derived, langerin  +   DDCs (marked with a star) are found adjacent to hair follicles. Results are representative of at least two experi-
ments. Ep, epidermis; D, dermis. Bar, 30    m.   JEM VOL. 204, December 24, 2007 
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migrated out from the ear of untreated   Lang-DTR-EGFP   mice 
segregated into CD45.2  high   and CD45.2  inter   subsets (  Fig. 2 B  ). 
Parallel analysis of B6 (CD45.1)   →     Lang-DTR-EGFP   chimeras 
CD11c-MHCII dot plots corresponding to the CD45.2  +   DCs 
present in the grafts showed that they contained blood-
derived, lymphoid-resident DC subsets only. Because they 
were totally deprived of tissue-derived (CD11c  inter to high  , 
MHCII  high  ) DCs, the CD11c-MHCII profi  les of the CLN 
and MLN grafts resembled those of transplanted pieces of 
spleen or of unmanipulated spleen (Fig. S5). Therefore, akin 
to LCs, langerin  +   DDCs presumably reach CLN via aff  erent 
lymphatic vessels. 
  The BrdU labeling kinetics of langerin  +   DDCs resemble that 
of langerin        DDCs 
  To examine the turnover of the langerin  +   DDCs and com-
pare it to that of LCs and langerin        DDCs,   Lang-DTR-
EGFP     →   B6 (CD45.1) chimeras were continuously exposed to 
BrdU for a week, and ear explants were prepared. DCs mi-
grating out of ear explants cultured in the presence of CCL21 
were gated on CD11c  +  , MHCII  +   DCs and analyzed using 
langerin-CD45.2 dot plot. We found that 7.7% of LCs (lan-
gerin  +  , CD45.2       ) and 49% of langerin  +   DDCs (langerin  +  , 
CD45.2  +  ) were labeled with BrdU within 7 d (  Fig. 5  ).   The 
slow BrdU labeling kinetics of LCs is consistent with previ-
ous data (  12, 21  ), and starkly contrasts with the faster BrdU 
labeling observed for langerin  +   DDCs. Interestingly, langerin        
DDCs exhibit a BrdU labeling rate that is of the same order 
(52.1%) as the one observed for langerin  +   DDCs. Therefore, 
half of the langerin  +   DDCs or their direct precursors have 
divided within the 7 d during which BrdU was administered. 
Analysis of langerin  +   DDCs for the expression of Ki-67, a 
nuclear antigen of which the expression refl  ects an active 
proliferative state, showed that most langerin  +   DDCs were 
Ki67        (unpublished data). Regardless of the exact nature 
of the proliferative progenitors (local langerin        precursors or 
continuously extravasating blood precursors) that replen-
ish the pool of langerin  +   DDCs, our data emphasize that the 
BrdU labeling kinetics of langerin  +   DDCs resembles that 
of langerin        DDCs and is markedly distinct from that of epi-
dermal LCs. 
  LCs and langerin  +   DDCs coexist in wild-type mice 
  Analysis of LC-derived DCs and langerin  +   DDC-derived 
DCs present in CLNs of BM chimeras showed that they are 
CD8           to low   and that they express rather similar levels of 
CD11c, CD205, and CD207 molecules (Figs. S2 and S3). 
The high levels of MHCII, CD40, and CD86 molecules they 
express are typical of tissue-derived DCs (Figs. S2 and S4). LC-
derived DCs and langerin  +   DDC-derived DCs also showed an 
overlapping anatomical distribution within the inner paracortex 
of CLNs (  Fig. 1 C  ). Extraction of langerin  +   DDCs from the 
skin of   Lang-DTR-EGFP     →   B6 (CD45.1) chimeras further 
revealed that   >  90% of them are CD11c  +   and MHCII  +   (un-
published data). 
  Based on a wealth of surface markers normally used to 
discriminate DC subsets, we failed to distinguish langerin  +   
DDCs and their derivatives from LCs and their derivatives. 
However, on langerin-CD45.2 dot plots, the langerin  +   DCs that 
    Figure 5.         BrdU incorporation of host- and donor-derived langerin  +   
DCs found in the skin.    Lang-DTR-EGFP      →     B6 (CD45.1) chimeras were 
exposed to BrdU for 1 wk, and ear explants were prepared. DCs migrating 
out of the ear explants were gated on CD11c  + ,  MHCII +   cells and analyzed. 
Three subsets can be distinguished using langerin versus CD45.2 dot plots: 
host-derived LCs (subset I: langerin  + ,  CD45.2     ,  EGFP     ),  donor-derived, 
langerin  +   DDCs (subset II: langerin  + ,  CD45.2 + ,  EGFP +  ), and donor-derived, 
langerin        DDCs (subset III: langerin      ,  CD45.2 + ,  EGFP      ). Histograms show 
BrdU incorporation for each subset. Gray-fi  lled histograms correspond to 
control staining profi  le of mice that received no BrdU. Percentages of BrdU  +   
cells are indicated. Results are representative of at least two experiments.    3126 DUAL ORIGIN OF LANGERIN  +   SKIN-DERIVED DCS | Poulin et al.
Therefore, DT treatment of B6 (CD45.1)   →     Lang-DTR-
EGFP   chimeras completely eliminated the local, host-derived, 
LC-generative compartment, allowing us to analyze whether 
showed that the CD45.2  high   subset is missing from langerin  +   
DCs that migrated out from CCL-21 ear explant and re-
placed by langerin  +  , CD45.2        donor DCs (  Fig. 2 B  ). More-
over, the langerin  +  , CD45.2  inter   subset left in B6 (CD45.1)   →   
  Lang-DTR-EGFP   chimeras disappeared after DT treatment 
(  Fig. 2 B  ). This suggests that the langerin  +   DDCs and LCs 
migrating out of ear explants are CD45.2  high   and CD45.2  inter  , 
respectively. Therefore, by combining such diff  erential ex-
pression of CD45.2 with the markedly distinct BrdU labeling 
kinetics observed for LCs and langerin  +   DDCs (  Fig. 2 B and 
Fig. 5  ), we reasoned that it should be possible to validate the 
existence of two distinct langerin  +   DC subsets in the skin of wild-
type mice. Accordingly, wild-type B6 (CD45.2) mice were left 
untreated or exposed to continuous BrdU labeling for 1 wk. 
Ear explants were prepared, and the CD11c  +  , MHCII  +   DCs 
migrating out of the explant analyzed using langerin-CD45.2 
contour plots. Two discrete subsets of langerin  +   DCs could 
readily be identifi  ed on the basis of CD45.2 levels (  Fig. 6  ). 
In support of the hints provided by   Fig. 2 B  , the CD45.2  inter  , 
langerin  +   subset showed BrdU labeling kinetics that resem-
bled those of LCs, whereas the CD45.2  high  , langerin  +   subset 
showed a rate of BrdU labeling comparable to langerin  +   DDCs 
(compare   Figs. 5 and 6  ).   Therefore, two subsets of langerin  +   
DCs can be discriminated in the skin of wild-type mice on 
the basis of the expression of CD45.2 and of BrdU labeling 
kinetics. LCs correspond to CD45.2  inter   cells with slow BrdU 
labeling kinetics, whereas langerin  +   DDCs correspond to 
CD45.2  high   cells with faster BrdU labeling kinetics. Although 
the two discrete clusters of CD45.2  high   and CD45.2  inter   langerin  +   
DCs tend to merge in the CLNs, the LC versus langerin  +   
DDC distinction still held true when cells belonging to both 
extremities of the CD45.2 distribution were analyzed (un-
published data). Therefore, both LCs and langerin  +   DDCs 
coexist in wild-type mice. 
  Colonization of emptied noninfl  ammatory epidermis 
by donor-derived LCs 
  Under steady-state conditions or upon minor skin injuries, re-
newal of the pool of epidermal LCs does not require any input 
from blood-borne, BM-derived cells. However, once a strong 
local infl  ammation is reached, e.g., through high-dose UV 
exposure, the local LC-generative compartment is destroyed 
(  12  ). The emptied epidermis is then slowly recolonized by 
LCs that derive from blood-borne precursors (  22  ). In contrast 
to high-dose UV exposure that induces a strong infl  ammation, 
DT treatment of B6 (CD45.1)   →     Lang-DTR-EGFP   chimeras 
provides the unique opportunity to ablate epidermal LCs in the 
absence of detectable infl  ammation (  9, 18  ), and to determine 
whether an LC-emptied, noninfl  ammatory adult epidermis is 
still competent to attract donor-derived cells capable of recon-
stituting the pool of epidermal LCs. 
  Epidermal sheets of ears from DT-treated B6 (CD45.1)   →   
  Lang-DTR-EGFP   chimeras were prepared and analyzed at 
various time points after the last DT injection. As shown in 
  Figs. 2, 3, and 7 , host-derived (EGFP  +  ) epidermal LCs were 
absent at all the time points analyzed (from 24 h to 7 wk).   
    Figure 6.         Wild-type langerin  +   DDCs express higher levels of 
CD45.2 than wild-type epidermal LCs.   Wild-type C57BL/6 (CD45.2  + ) 
mice were left untreated or exposed to BrdU for 1 wk, and ear explants 
were prepared and cultured in the presence of CCL21. The MHCII  + ,  CD11c +  
DCs migrating out of the ear explants were analyzed using langerin-
CD45.2 plots. Two discrete subsets can be readily discriminated among 
langerin  +   DCs according to the levels of CD45.2 they express. Subset I 
corresponds to LCs and expresses intermediate levels of CD45.2, whereas 
subset II corresponds to langerin  +   DDCs and expresses high levels of 
CD45.2. Subset III corresponds to langerin        DDCs. Histograms show BrdU 
incorporation for each subset. Gray-fi  lled histograms correspond to con-
trol staining profi  le of mice that received no BrdU. Percentages of BrdU  +  
cells are indicated. Results are representative of at least two experiments.     JEM VOL. 204, December 24, 2007 
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an LC-free, noninfl  ammatory, adult epidermis has the capac-
ity to be repopulated with BM-derived LCs. As shown in 
  Fig. 7 A , the emptied epidermis of DT-treated B6 (CD45.1)  →   
  Lang-DTR-EGFP   chimeras was, indeed, recolonized with 
donor-derived (langerin  +  , EGFP       ) LCs. Interestingly, repop-
ulation of the adult epidermis occurred very slowly, and at 
1 wk after the last DT injection, only sparse foci of langerin  +   
cells with a DC morphology were observed (  Fig. 7 A  ). 4 wk 
after the last DT injection, langerin  +   cells still showed a patchy 
distribution, suggesting that the whole ear epidermis is repopu-
lated by only a few donor-derived cells, the clonal progeny 
of which start to merge only at later time points (  Fig. 7 A  ). 
Microscopic analysis of a skin section of a DT-treated B6 
(CD45.1)   →     Lang-DTR-EGFP   chimera 7 wk after the last DT 
injection confi  rmed the presence of langerin  +   cells within the 
epidermis (  Fig. 7 A  ). Therefore, the use of DT-treated B6 
(CD45.1)  →    Lang-DTR-EGFP   chimeras instead of DT-treated 
  Lang-DTR-EGFP   mice (  9, 18  ), permitted us to establish that 
an LC-emptied, noninfl  ammatory epidermis can be recon-
stituted through BM-derived precursors rather than through 
host-derived, langerin        (DT-unsensitive) LC precursors. In-
terestingly, the slow kinetics of reappearance of the epidermal 
LCs observed in B6 (CD45.1)   →     Lang-DTR-EGFP   chimera 
after DT treatment resembles that noted under strong infl  am-
matory conditions (  22  ). These two observations are thus in 
marked contrast with the fast kinetics of reappearance noted 
for langerin  +   DDCs and their derivatives (  Fig. 4  ), suggesting 
that the epidermal environment might lower the rate of 
LC division. 
    DISCUSSION   
  Two subsets of langerin  +   DCs are currently distinguished in 
steady-state CLNs (  9, 23  ). The main subset represents     90% 
of the langerin  +   cells and shows a tissue-derived phenotype 
(CD11c  inter to high  , MHCII  high  ) matching that expected for 
LC-derived DCs. The second subset represents     10% of the 
langerin  +   fraction and corresponds to lymphoid tissue  –  resident, 
langerin  low  , CD8      +   DCs. In this study, we showed that the 
langerin  +  , CD11c  inter to high  , MHCII  high   DC subset origi-
nates from two independent developmental pathways that 
coexist in steady-state conditions. The fi  rst pathway corre-
sponds to the paradigmatic pathway established for radioresis-
tant epidermal LCs and for their derivatives found in CLNs. 
The second pathway originates from langerin  +   CD11c  +   
MHCII  +   DCs that reside in the dermis. These langerin  +   DDCs 
are radiosensitive and should not be confused with migratory 
epidermal LCs that coexist in the dermis of steady-state mice 
and are en route to the CLNs. After migrating through lym-
phatic vessels, both LC-derived DCs and langerin  +   DDC-
derived DCs colocalize into the T-cell zones of the CLNs. 
In DT-treated B6 (CD45.1)   →     Lang-DTR-EGFP   chimeras, 
langerin  +   DDC-derived DCs can be observed in CLNs even 
at the earliest time points after DT treatment, a period charac-
terized by the absence of epidermal LCs. Therefore, langerin  +   
DDCs do not appear to develop through a default pathway 
that operates only when precursor cells are prevented from 
reaching LC-replete epidermis. Using combined CD45.2 ex-
pression and BrdU labeling kinetics, we further showed that 
epidermal LCs and langerin  +   DDCs are present in the skin of 
wild-type mice, and thus do not constitute artifacts resulting 
from the use of BM chimeras. Therefore, langerin alone is not 
a reliable marker to identify LC outside the epidermis and the 
skin-derived, langerin  +  , CD8           to low   DCs proper to CLNs 
include two subsets that markedly diff  er in their develop-
mental origin (Fig. S6). 
  DT-mediated ablation of the radioresistant epidermal LCs 
present in B6 (CD45.1)   →     Lang-DTR-EGFP   chimeras 
opened otherwise fi  lled niches in the absence of detectable 
infl  ammation. This maneuver allowed the seeding of the epi-
dermis with incoming donor-derived LCs. Seeding occurred 
in a focal manner, suggesting that the pool of reconstituted 
epidermal LCs stems from the progeny of only a few cells. 
In the case of adult steady-state epidermis, it has been questioned 
whether local LC renewal is achieved through LC precursors 
with stem-cell properties or through division of diff  erentiated 
LCs. The observation that the LC clusters developing around 
the fi  rst langerin  +   incoming cells expand centrifugally with age 
suggests that diff  erentiated LCs self-duplicate within the epi-
dermis, although proliferation and diff  erentiation in the dermis 
and a subsequent focused migration into the epidermis cannot 
be excluded. In support of the fi  rst view, it should be noted that 
after acute injuries, liver regeneration occurs through pro-
liferation of hepatocytes and without obvious participation 
of stem cells (  24  ). 
  When parabiotic mice are separated after DC   “  equilibra-
tion,  ”   lymphoid tissue  –  resident DCs present in the spleen 
and originating from the separated partner reach background 
levels by 10  –  14 d, and are replaced by blood-borne precur-
sors (  17  ). A similar trend, corresponding to a 5  –  7-d half-life, 
is also observed for the tissue-derived (MHC  high  ) DCs found 
in CLNs and originating from the separated partner (  17  ). Al-
though this compartment was analyzed without segregating it 
into the derivatives of LCs, of langerin  +   DDCs, and of lan-
gerin        DDCs, the bulk of it also reached background levels 
by 10  –  14 d (  17  ). After DT ablation, we found that the pool 
of langerin  +   DDCs is almost completely reconstituted over a 
14-d period. It is thus tempting to speculate that blood pre-
cursors are continuously recruited into noninfl  ammatory 
dermis to replace langerin  +   DDCs en route to the CLNs. In 
the chimeric mice used in this study, donor-derived langerin  +   
DDCs represented approximately a third of the langerin  +   
DCs capable of being mobilized from ear explants (  Fig. 2 B  ). 
In the corresponding CLNs, the donor-derived langerin  +   
CD11c  inter to high  , MHCII  high   DCs that are expected to derive 
from langerin  +   DDCs comprised from 60% (  Lang-DTR-
EGFP    →   B6 [CD45.1] chimeras;  Fig. 1 ) to 70% (B6 [CD45.1] 
  →     Lang-DTR-EGFP   chimeras;   Fig. 3  ) of the langerin  +   
CD8           to low   DCs. The distortion that exists in the ratio of 
LCs/langerin  +   DDCs in CCL21-treated ear explants and of 
LC-derived DCs/langerin  +   DDC-derived DCs in CLNs sug-
gests that CCL21 treatment might favor the migration of LCs. 
Alternatively, a fraction of the donor-derived, langerin  +   3128 DUAL ORIGIN OF LANGERIN  +   SKIN-DERIVED DCS | Poulin et al.
    Figure 7.         Donor-derived LCs colonize emptied epidermal niches.   B6 (CD45.1)   →    Lang-DTR-EGFP   chimeras that had received 3 injections of DT 1 wk 
apart were analyzed at various time points after the last injection. (A) Epidermal sheets 1 (a), 4 (b), and 7 wk (c) after the last DT injection were stained 
with anti-langerin antibody (red) and ToPro3 blue. Rare patches of donor-derived LCs (langerin  +   EGFP      ) were found 1 wk after the last injection (arrow). 
An enlarged view (206.8   ×   206.8   μ  m) of one of these patches is shown in the top right corner of a. d corresponds to a section of an ear from a DT-treated 
B6 (CD45.1)   →    Lang-DTR-EGFP   chimera 7 wk after the last DT injection costained with anti-langerin (red) and   –  keratin 5 (blue) antibodies. Donor-derived 
LCs are found in both the dermis and epidermis. Bars: (a  –  c) 200     m; (d) 50     m. Results are representative of at least two experiments with two to three 
mice per experiment. Ep, epidermis; D, dermis. (B) Analysis of tissue-derived (CD11c  inter to high ,  MHCII high  ) DCs present in the CLNs from untreated and DT-
treated B6 (CD45.1)   →    Lang-DTR-EGFP   chimera. In the case of the DT-treated mice, CLNs were analyzed 7 wk after the last DT-injection. Dot plots show 
langerin-EGFP distribution. Consistent with the results shown in A, 7 wk after the last DT injection, the CLNs of DT-treated B6 (CD45.1)   →    Lang-DTR-EGFP  
chimera are deprived of host-derived LCs and contain an abundant population of donor-derived LCs. Results are representative of at least 
two experiments.     JEM VOL. 204, December 24, 2007 
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of human langerin  +   DCs endow such cells with unique anti-
gen uptake and processing capacities (  29, 30  ). Therefore, the 
rapidly renewing langerin  +   DDC subset described in this 
study might provide the host with a second line of defense 
to react to pathogens that naturally infect the dermis or that 
reach it via a disrupted epithelial barrier. Mouse strains lacking 
T, B, and NK cells support engraftment and diff  erentiation of 
human hematopoietic stem cells. Such humanized mice have 
allowed us to model issues such as intervention in HIV-1 in-
fections and hematopoietic and immune system gene therapy. 
However, as recently outlined by Manz (  31  ), these mice pre-
sent major limitations and need further improvements to make 
them appropriate for human immunology research. Particu-
larly relevant to this data, their epidermis remains populated 
with radioresistant LCs of mouse origin. We have shown that 
DT-mediated ablation of the host-derived, radioresistant epi-
dermal LCs present in B6 (CD45.1)   →     Lang-DTR-EGFP   
chimeras allows the replenishment of the epidermis with 
donor-derived LCs. Applying a similar strategy to humanized 
mouse models carrying a   Lang-DTR-EGFP   allele should 
thus facilitate the colonization of the mouse epidermis by 
epidermal LCs of human origin and contribute to improving 
such models. 
    MATERIALS AND METHODS   
  Mice.     C57BL/6 female mice that express the CD45.1 (B6 [CD45.1]) or 
CD45.2 (B6 [CD45.2]) allele of CD45 were purchased from Charles River 
Laboratories.   Langerin-EGFP   and   Langerin-DTR-EGFP   mice have been pre-
viously described (  9  ) and crossed onto the B6 background for at least 10 
generations. Mice were housed under specifi  c pathogen-free conditions and 
handled in accordance with French and European directives (DDSV des 
Bouches du Rh  ô  ne). 
  Transplantation of BM cells.     7  –  8-wk-old B6 (CD45.1) mice were le-
thally irradiated with 2 doses of 475 rads each, 5 h apart, and then injected 
i.v. with BM cells (2   ×   10  6  ) obtained from adult CD45.2  +     Lang-DTR-
EGFP-DTR   mice. In the case of B6 (CD45.1)   →     Lang-DTR-EGFP   chi-
mera, proper engraftment was obtained by irradiating the recipient mice 
with 2 doses of 550 rads each, 5 h apart, and i.v. injection with 5   ×   10  6   BM 
cells isolated from B6 (CD45.1) mice. 7  –  8 wk after reconstitution, the level 
of blood chimerism was determined. Chimeras were kept on antibiotic-con-
taining water (0.2% Bactrim; Roche) during the whole experiment. 
  Preparation and staining of epidermal sheets.     Epidermal sheets were 
prepared as previously described (  20  ), and their integrity was systematically 
assessed by counterstaining with the nuclear stain ToPro3. 
  DC isolation.     DCs were isolated from lymphoid organs, as previously de-
scribed (  32  ). In brief, the organs were fi  rst cut in small pieces and incubated 
with a mixture of type II collagenase (Worthington Biochemical) and of 
DNase (Sigma-Aldrich). Light density cells were purifi  ed by centrifugation 
on a Nycoprep solution (density = 1.068). DCs were isolated from cultured 
ear skin explants, as previously described (  20  ). 
  Flow cytometry.     Before staining, cells were preincubated on ice for at least 
10 min with the 2.4 G2 mAb to block Fc receptors. Multiparameter FACS 
analysis was performed using an LSR or a FACSCanto system (BD Biosci-
ences). FACS data were analyzed using FlowJo software (Tree Star, Inc.). 
For each experiment, control mice (B6 [CD45.2], B6 [CD45.1], and   Lang-
DTR-EGFP   mice) were included to defi  ne the proper gates. Autofl  uorescent 
CD11c  inter to high  , MHCII  high   DCs found in the CLNs of the chi-
meras can originate from precursors that are recruited directly 
to the CLNs from the blood. It has been shown that an 
infl  ammed skin can project its chemokine profi  le to the 
high endothelial venules of CLNs, and thereby exert some 
  “  remote control  ”   on the composition of the leukocytes that 
home to the CLNs from the blood (  25  ). Likewise, in non-
infl  ammatory skin, inductive signals might also be projected to 
CLNs via aff  erent lymphatics and allow the diff  erentiation of 
blood-derived precursors into langerin  +   CD11c  inter to high  , 
MHCII  high   DCs. If proven, the existence of such inductive 
mechanisms will question the categorization of DCs into 
lymphoid tissue  –  resident and tissue-derived subsets be-
cause they will confer a bona fi  de tissue-derived phenotype 
(MHCII  high  , CD40  +  , CD86  +  ; Figs. S2 and S4) to DCs that never 
resided in the skin. However, as demonstrated in a compan-
ion paper (  26  ), through the use of mice that lack the chemo-
kine receptor CCR7, most of the langerin  +  , CD8           to low   
DCs likely reach CLNs through skin aff  erent lymphatics, and 
thus constitute the direct progeny of LCs and of langerin  +   
DDCs (Fig. S6). 
  The exact function of LCs remains enigmatic. For in-
stance, in a mouse model of HSV infection, LCs were found 
dispensable for the generation of viral-specifi  c eff  ector T cells 
(for review see [  2  ]), and confl  icting results were reached as to 
the role of LCs in triggering hapten-specifi  c T cell eff  ectors 
through skin immunization (  9, 18, 27  ). Eff  orts aiming at de-
termining the relative contribution of epidermal LCs and 
DDCs in the presentation of skin-delivered pathogen anti-
gens have generally relied on the use of BM chimeras that use 
recipients expressing the H-2 K  bm1   gene (  28  ). This natural 
variant gene arose by gene conversion from the H-2 K  b   gene, 
and its product is incapable of presenting a peptide derived 
from HSV and recognized by the gBT-I T-cell antigen re-
ceptor. Accordingly, the whole population of langerin  +  , 
skin-derived DCs present in CLNs of H-2 K  b     →   H-2 K  bm1   
chimeras was inferred to express H-2 K  bm1  , and thus to be 
unable to present the HSV-derived peptide. This conclusion 
should, however, be revised on the basis of this study because 
langerin  +   DDC-derived DCs present in H-2 K  b     →   H-2 K  bm1   
chimeras would be expected to express H-2 K  b  , and thus 
contribute to trigger gBT-I T cells in addition to langerin        
DDC-derived DCs. Further experiments aiming at probing 
the role of langerin  +   DCs and relying on H-2 K  b     →   H-2 
K  bm1   chimeras should thus take into consideration the existence 
of two langerin  +  , skin-derived DC subsets that markedly 
diff  er in their origin and radioresistance. 
  Finally, it remains to determine whether some functional 
specialization exists among the two types of langerin  +   skin-
derived DC subsets described in this study. For instance, the 
TGF-    1 rich epidermal environment might specifically 
lower the capacity of LCs to present antigen in an immuno-
genic form. Provided it extends to humans, the LCs versus 
langerin  +   DDCs dichotomy described in this study might also be 
important to take into consideration during HIV-1 infection. 
For instance, the langerin molecules that decorate the sur  face 3130 DUAL ORIGIN OF LANGERIN  +   SKIN-DERIVED DCS | Poulin et al.
found in steady-state CLNs. The online version of this article is available at 
http://www.jem.org/cgi/content/full/jem.20071724/DC1. 
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cells were gated out by using the FL3 (LSR) or AmCyan (Canto) channel. 
In a few experiments, the fi  xation procedure used to detect the surface and 
intracellular content of langerin resulted in some EGFP leak and DCs with 
the lowest EGFP intensity scored in the langerin  +   EGFP        quadrant of lan-
gerin-EGFP plots. The langerin versus CD45.2 staining is not prone to such 
a caveat, and it gives the correct relative percentages of cells. For instance, 
in   Fig. 1 B  , correction of the langerin-EGFP plots for such a leak (4.5%) 
resulted in percentages of donor- and host-derived EGFP  +   cells that are 
congruent with those based on langerin-CD45.2 staining. 
  Antibodies.     CD11c (HL3), CD8     (53  –  6.7), CD40 (HM40-3), MHCII 
(M5/114 or AF6-120.1), CD86 (GL1), CD45.2 (104), CD45.1 (A20), and 
B220 (RA3-6B2) antibodies were all purchased from BD Biosciences, ex-
cept for CD205 (CL89145; Cedarlane Laboratories), CD115 (AFS98; eBio-
science), and the anti-langerin antibody (929F3; Dendritics). 
  Histology, immunostaining, and confocal microscopy.     LNs and ears 
were fi  xed by incubating them on ice for 1  –  2 h in PBS containing 3.2% 
PFA. To preserve cell morphology, organs were briefl  y washed in PBS and 
transferred to a 35% sucrose solution for 24  –  48 h. Fixed tissues were frozen 
in Tissue-Tec OCT on dry ice and stored at     80  °  C until further processing. 
Cryosections (20   μ  m thick) were rehydrated in PBS and permeabilized by 
placing them in PBS with 0.5% saponin for 10 min. After washing in PBS, 
nonspecifi  c antibody-binding sites were blocked with PBS, 1% FCS, 2% 
normal goat serum, and 2% BSA. Cryosections were stained overnight at 
4  °  C with the primary antibody. After a wash in PBS, the secondary antibody 
was added for 2 h at room temperature. Finally, cryosections were washed 
successively in PBS and water and mounted in ProLong Gold antifade re-
agent (Invitrogen). Rabbit anti-EGFP antibody (clone TP401; Torrey Pines 
Biolabs) and rat anti-langerin antibody (clone 929F3; Dendritics) were re-
vealed using an Alexa Fluor 488 goat anti  –  rabbit IgG and an Alexa Fluor 546 
goat anti  –  rat IgG, respectively (Invitrogen). Rat anti-langerin antibody and 
rabbit anti-keratin 5 antibody (clone AF138; Eurogentec) were revealed us-
ing an Alexa Fluor 546 goat anti  –  rat IgG and an Alexa Fluor 647 goat anti  –
  rabbit IgG, respectively. Images were acquired on a confocal microscope 
(LSM 510; Carl Zeiss, Inc.). 
  In vivo depletion of LCs.     For systemic in vivo depletion of langerin  +   
DCs, mice were injected i.p. with 1   μ  g DT (Servibio). Mice were analyzed 
at diff  erent time points after the last DT injection. 
  BrdU labeling in vivo and cell cycle analyses.     Mice were injected i.p. 
with 1.5 mg BrdU (Sigma-Aldrich) to ensure its immediate availability, and 
their drinking water was supplemented for 1 wk with 0.8 mg/ml of BrdU 
and 2% glucose and changed daily. DCs collected from ear explants were 
stained fi  rst for surface markers and then permeabilized for BrdU staining 
(BrdU labeling Flow kit; BD Biosciences) and langerin staining. 
  Renal capsule grafting.     Spleen pieces were grafted under the renal capsule 
according to an online procedure (http://mammary.nih.gov/tools/mouse-
work/cunha001/index.html). This protocol was recently used to determine 
the origin of the DCs found in the spleen (  17  ), and extended in this study to 
total or to pieces of CLNs and MLNs. To avoid necrosis of the center of the 
graft before revascularization, the largest dimension of the grafted piece did 
not exceed 2 mm. 
  Online supplemental material.     Fig. S1 shows the extent of chimerism 8 
wk after BM transplantation. Fig. S2 shows that DC subsets found in CLNs, 
MLNs, and spleen of chimeric mice have an expected developmental origin 
and anatomical distribution. Fig. S3 compares CD205 and CD8     expression 
on LC-derived DCs and langerin  +   DDC-derived DCs from chimeric and 
  Lang-DTR-EGFP   mice. Fig. S4 shows that both host- and donor-derived 
DCs from steady-state CLNs of chimeric mice display a mature phenotype. 
Fig. S5 shows host DC development in grafted pieces of secondary lymphoid 
organs. Fig. S6 shows a model of the origin of the three langerin  +   DC subsets JEM VOL. 204, December 24, 2007 
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